Prestimulation parameters predicting live birth in anovulatory WHO Group II patients undergoing ovulation induction with gonadotrophins

Human Reproduction

Volumn 25, Issue 8, 2010, Pages 1988-1995

  Nyboe Andersen, A ^a   Balen, A H ^b   Platteau, P ^c   Pettersson, G ^d   Arce, J C ^d  

^a University of Copenhagen   (Denmark)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

^c CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

^d Ferring Pharmaceuticals AS   (Denmark)

Author keywords

anovulation; gonadotrophin; live birth; nomogram; prediction model

Indexed keywords

ANDROGEN; CLOMIFENE CITRATE; FOLLITROPIN; GLUCOSE; GONADOTROPIN DERIVATIVE; INSULIN; LUTEINIZING HORMONE;

ADULT; ARTICLE; BODY MASS; FEMALE; FEMALE INFERTILITY; HORMONE BLOOD LEVEL; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; NOMOGRAM; OVULATION INDUCTION; PARAMETER; PREDICTION; WORLD HEALTH ORGANIZATION;

EID: 77954963501     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deq142     Document Type: Article

References (22)

1. Balen AH, Platteau P, Andersen AN, Devroey P, Sørensen P, Helmgaard L, Arce J-C. The influence of body weight on response to ovulation induction with gonadotrophins in 335 women with World Health Organization group II anovulatory infertility. BJOG 2006; 113:1195-1202.
2. Balen A, Platteau P, Nyboe Andersen A, Devroey P, Helmgaard L, Arce J-C, for the Bravelle Ovulation Induction (BOI) Study Group. Highly purified FSH is as efficacious as recombinant FSH for ovulation induction in women with WHO Group II anovulatory infertility: a randomized controlled non-inferiority trial. Hum Reprod 2007; 22:1816-1823.
3. Eijkemanns MJC, Imani B, Mulders AGMGJ, Habbema JDF, Fauser BCJM. High singleton live birth rate following classical ovulation induction in normogonadotrophic anovulatory infertility (WHO 2). Hum Reprod 2003;18:2357-2362.
4. Fauser BCJM, Diedrich K, Devroey P, on behalf of the Evian Annual Reproduction (EVAR) Workshop Group 2007. Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation. Hum Reprod Update 2008;14:1-14.
5. Hendriks DJ, Mol BW, Bancsi LF, Te Velde ER, Broekmans FJ. Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level. Fertil Steril 2005; 83:291-301.
6. Homburg R. Clomiphene citrate-end of an era? A mini-review. Hum Reprod 2005;20:2043-2051.
7. Imani B, Eijkemans MJ, te Velde ER, Habbema JD, Fauser BC. Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 1998;83:2361-2365.
8. Imani B, Eijkemans MJ, te Velde ER, Habbema JD, Fauser BC. Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 1999;84:1617-1622.
9. Imani B, Eijkemans MJ, Faessen GH, Bouchard P, Giudice LC, Fauser BC. Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility: an approach to increase safety and effciency. Fertil Steril 2002;77:83-90.
10. Kousta E, White DM, Franks S. Modern use of clomiphene citrate in induction of ovulation. Hum Reprod Update 1997;3:359-365.
11. Li RHW, Van Esch M, De Vries J, Colin Duncan W, Anderson RA. Gonadotrophin ovulation induction is a successful treatment for World Health Organisation Group II anovulatory subfertility in women aged up to 40 and with body mass index up to 34. Hum Fertil 2010;13:35-40.
12. Messinis IE, Milingos SD. Current and future status of ovulation induction in polycystic ovary syndrome. Hum Reprod Update 1997; 3:235-253.
13. Mulders AG, Eijkemans MJ, Imani B, Fauser BCJM. Prediction of chances for success or complications in gonadotrophin ovulation induction in normogonadotrophic anovulatory infertility. Reprod Biomed Online 2003a;7:48-56.
14. Mulders AGMGJ, Laven JSE, Eijkemans MJC, Hughes EG, Fauser BCJM. Patient predictors for outcome with gonadotropin ovulation induction in women with normogonadotrophic anovulatory infertility: a metaanalysis. Hum Reprod Update 2003b;9:429-449.
15. Platteau P, Nyboe Andersen A, Balen A, Devroey P, Sørensen P, Helmgaard L, Arce J-C, for the Menopur Ovulation Induction (MOI) Study Group. Similar ovulation rates, but different follicular development with highly purified menotrophin compared with recombinant FSH in WHO Group II anovulatory infertility: a randomized controlled study. Hum Reprod 2006;21:1798-1804.
16. Practice Committee, ASRM. Use of clomiphene citrate in women. Fertil Steril 2006;86:S187-S193.
17. Rausch ME, Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, Steinkampf MP, McGovern PG, Cataldo NA et al. Reproductive Medicine Network. Predictors of pregnancy in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2009;94:3458-3466.
18. Steyerberg EW, Eijkemans MJC, Habbema JDF. Application of shrinkage techniques in logistic regression analysis: a case study. Stat Neerl 2001; 55:76-88.
19. Templeton A, Morris JK, Parslow W. Factors that affect outcome of in-vitro fertilisation treatment. Lancet 1996;348:1402-1406.
20. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod 2008;23:462-477.
21. van Wely M, Bayram N, van der Veen F, Bossuyet PMM. Predicting ongoing pregnancy following ovulation induction with recombinant FSH in women with polycystic ovarian syndrome. Hum Reprod 2005; 20:1827-1832.
22. World Health Organization. WHO Manual for the Standardized Investigation and Diagnosis of the Infertile Couple. Cambridge, UK: Cambridge University Press, 1993.